Does TACROLIMUS Cause Disseminated intravascular coagulation? 278 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 278 reports of Disseminated intravascular coagulation have been filed in association with TACROLIMUS (Tacrolimus). This represents 0.3% of all adverse event reports for TACROLIMUS.
278
Reports of Disseminated intravascular coagulation with TACROLIMUS
0.3%
of all TACROLIMUS reports
203
Deaths
208
Hospitalizations
How Dangerous Is Disseminated intravascular coagulation From TACROLIMUS?
Of the 278 reports, 203 (73.0%) resulted in death, 208 (74.8%) required hospitalization, and 109 (39.2%) were considered life-threatening.
Is Disseminated intravascular coagulation Listed in the Official Label?
Yes, Disseminated intravascular coagulation is listed as a known adverse reaction in the official FDA drug label for TACROLIMUS.
What Other Side Effects Does TACROLIMUS Cause?
Off label use (8,718)
Drug ineffective (6,214)
Product use in unapproved indication (5,057)
Acute kidney injury (4,005)
Transplant rejection (3,526)
Cytomegalovirus infection (3,320)
Covid-19 (3,201)
Drug interaction (2,896)
Diarrhoea (2,854)
Toxicity to various agents (2,845)
What Other Drugs Cause Disseminated intravascular coagulation?
PREDNISOLONE (362)
METHOTREXATE (347)
DEXAMETHASONE (323)
METHYLPREDNISOLONE (307)
NIVOLUMAB (305)
CYCLOPHOSPHAMIDE (286)
PREDNISONE (277)
VINCRISTINE (245)
OXALIPLATIN (231)
MYCOPHENOLATE MOFETIL (224)
Which TACROLIMUS Alternatives Have Lower Disseminated intravascular coagulation Risk?
TACROLIMUS vs TACROLIMUS\TACROLIMUS ANHYDROUS
TACROLIMUS vs TADALAFIL
TACROLIMUS vs TAFAMIDIS
TACROLIMUS vs TAFAMIDIS MEGLUMINE
TACROLIMUS vs TAFASITAMAB